Indigenous, immunocompromised and other vulnerable children as young as 12 will be given priority access to Pfizer’s COVID-19 vaccine.
Indigenous, immunocompromised and other vulnerable children as young as 12 will be given priority access to Pfizer’s COVID-19 vaccine.